Sabine Hutchison talks to the inspiring investor Stephanie Oestreich. In the first episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the inspiring Stephanie Oestreich, whose work at the Myeloma Investment Fund (MIF) involves applying financial investment, scientific knowledge and valuable connections to reach a cure for every single Myeloma patient. At MIF, Stephanie uses the investment and drug development knowledge and skills she has gained in several leadership roles in biotech and big pharma. In this engaging conversation, Sabine talks to Stephanie about t ..read more

Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabine to discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies ..read more

Sabine Hutchison sits down with the incredible Viviënne van de Walle a highly respected principal investigator who brings her wealth of experience to the table, blending clinical research with patient care. As they explore the critical role of communication in successful collaborations, Viviënne shares her insights, stories, and even a bit of humor ..read more

In Episode 4 of "Cut the Chat," host Sabine Hutchison engages in a thought-provoking discussion with Ben Osborn, a prominent figure in the biopharma industry and President of the Europe Eastern Cluster at IDM. This episode explores the dynamic interplay of diversity, equity, and inclusion (DE&I) within the pharmaceutical and biotech sectors. The DE&I landscape is vast, intricate, and undeniably crucial, touching on various aspects such as gender, religion, family status, education, nationality, and work background ..read more

Join Seuss+ CEO and Co-Founder Sabine Hutchison as she sits down with the accomplished Dr. Allison Jeynes-Ellis, a visionary leader whose journey spans medicine, oncology, and the life sciences. With over three decades of experience, Allison has held key positions in esteemed institutions and collaborated with pharmaceutical giants like Roche, AstraZeneca, and J&J. In this episode, they delve into Allison’s remarkable journey from practicing medicine to assuming the role of CEO at Avillion LLP. Renowned for its innovative life sciences investment approach, Avillion co-develops and finances ..read more

Seuss+ CEO and Co-Founder Sabine Hutchison delves into the remarkable growth strategy and remarkable journey of Agenus Bio, a standout player in the competitive Biotech industry. This unique organization chooses to be purposefully different. Jennifer reveals the story behind their success, discussing the importance of in-house capabilities, a patient-focused approach, and strategic collaborations that have set them apart in this heavily regulated field. Sabine and Jennifer explore the captivating world where science and creativity unite. Discover their secrets to success and get inspired by th ..read more